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https://doi.org/10.1002/nbm.3761Ectopic lipid accumulation in the liver is implicated in metabolic disease in an age‐ and sex‐depen-
dent manner. The role of hepatic lipids has been well established within the scope of metabolic
insults in mice, but has been insufficiently characterized under standard housing conditions,
where age‐related metabolic alterations are known to occur. We studied a total of 10 male and
10 female mice longitudinally. At 3, 7 and 11 months of age, non‐invasive 1H‐magnetic resonance
spectroscopy (1H‐MRS) was used to monitor hepatic lipid content (HLC) and fatty acid
composition in vivo, and glucose homeostasis was assessed with glucose and insulin challenges.
At the end of the study, hepatic lipids were comprehensively characterized by nuclear magnetic
resonance (NMR) and liquid chromatography‐mass spectrometric analyses of liver tissue samples.
In males, HLC increased from 1.4 ± 0.1% at 3 months to 2.9 ± 0.3% at 7 months (p < 0.01) and 2.7
± 0.3% at 11 months (p < 0.05), in correlation with fasting insulin levels (p < 0.01, r = 0.51) and
parameters from the insulin tolerance test (ITT; p < 0.001, r = –0.69 versus area under the curve;
p < 0.01, r = –0.57 versus blood glucose drop at 1 h post‐ITT; p < 0.01, r = 0.55 versus blood
glucose at 3 h post‐ITT). The metabolic performance of females remained the same throughout
the study, and HLC was higher than that of males at 3 months (2.7 ± 0.2%, p < 0.01), but
comparable at 7 months (2.2 ± 0.2%) and 11 months (2.2 ± 0.1%). Strong sexual dimorphism in
bioactive lipid species, including diacylglycerols (higher in males, p < 0.0001),
phosphatidylinositols (higher in females, p < 0.001) and omega‐3 polyunsaturated fatty acids
(higher in females, p < 0.01), was found to be in good correlation with metabolic scores at 11
months. Therefore, in mice housed under standard conditions, sex‐specific composition of bioac-
tive lipids is associated with metabolic protection in females, whose metabolic performance was
independent of hepatic cytosolic lipid content.
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Obesity is known to be associated with diseases in which severe metabolic dysregulation is present, including cardiovascular disease, cancer and
type 2 diabetes. The metabolic risk is further aggravated by aging‐associated adiposity1-3 in a gender‐dependent manner. For instance, even though
women generally display a proportionally higher amount of adipose tissue than men, they are at a lower metabolic risk. This feature may beAGC, automatic gain control; ANOVA, analysis of variance; AUC, area under the curve; Cer, ceramide; DAG,
ent assay; GlcCer, glucosylceramide; HLC, hepatic lipid content; HR‐NMR, high‐resolution, liquid‐state, nuclear
‐MS, liquid chromatography‐mass spectrometry; LBPA, lyso‐bis‐phosphatidic acid; MCL, mean chain length; MRS,
ucose tolerance test; PG, glycerophosphoglycerol; PKC, protein kinase C; PtdCho, phosphatidylcholine; PtdEt,
sitol; PtdSer, phosphatidylserine; PUFA, polyunsaturated fatty acid; QUICKI, quantitative insulin sensitivity check
of the mean; SFA, saturated fatty acid; SLBPA, semi‐lyso‐bis‐phosphatidic acid; SM, sphingomyelin; STEAM,
; UFA, unsaturated fatty acid; VAPOR, variable power RF pulses with optimized relaxation delays
Copyright © 2017 John Wiley & Sons, Ltd.wileyonlinelibrary.com/journal/nbm 1 of 14
2 of 14 SOARES ET AL.explained by sex‐specific fat distribution that favors subcutaneous versus visceral depots in women, thereby offering them protection against
metabolic disease.2,4
Dietary, surgical and genetic manipulations in male rodents have shown that inflammation, visceral fat and hepatic steatosis are strong
determinants shifting obesity towards metabolic disease.5-7 In particular, hepatic steatosis may lead to insulin resistance independent of weight
gain.8 Given the strong relationship between visceral fat and hepatic steatosis,9,10 sexual dimorphism in hepatic fat storage probably plays a role
in the susceptibility to metabolic disease. Accordingly, the prevalence of non‐alcoholic fatty liver disease is lower in women than men,11 and
post‐prandial hepatic lipid storage is greater in male than in female volunteers.12 Epidemiological and clinical experimental findings are reflected
in rodent studies, demonstrating that females are protected against hepatic steatosis and related metabolic dysregulation in models of diet‐induced
obesity13-15 and also in aging mice.16
Laboratory rodents with limited space and free access to food may be considered as natural models of a sedentary lifestyle17 and, indeed, show
features of aging‐associated obesity and metabolic disease.5 However, the contribution of hepatic lipids to metabolic dysregulation in mice housed
under standard conditions has been poorly addressed and is likely to exhibit sexual dimorphism. Thus, in this study, we monitored possible changes
in hepatic lipid content (HLC) and fatty acid composition (throughout the article, the designation ‘fatty acid’ refers to fatty‐acyl chains in lipid
molecules rather than to free fatty acids) over several months in mice housed under standard conditions. These longitudinal measurements were
performed with 1H‐magnetic resonance spectroscopy (1H‐MRS) in vivo, a powerful technique that has been used to monitor both lipid
accumulation18-20 and depletion.21 In order to examine the specific relationship between hepatic lipids and the anticipated sex differences in
metabolic performance, we performed glucose and insulin challenges throughout the study. Lipidomics data from high‐resolution, liquid‐state,
nuclear magnetic resonance (HR‐NMR) and liquid chromatography‐mass spectrometry (LC‐MS) analysis of liver samples collected at the end of
the study provided complementary information on the complete hepatic lipid profile.2 | MATERIALS AND METHODS
2.1 | Animals
Experiments were performed with the approval of the local ethics committee (Service de la consummation et des affaires vétérinaires, Epalinges,
Switzerland). Male (N = 10) and female (N = 10) C57BL/6J mice (Charles River Laboratories, L'Arbresle, France) were housed, five per cage, in a 12‐h
light/12‐h dark cycle (lights on at 07:00 h) with free access to water and a chow diet (Kliba‐Nafag, Kaiseraugst, Switzerland). The diet was
composed of 18.8% (m/m) protein, 5.6% (m/m) fat (from soybean oil) and 54.6% (m/m) nitrogen‐free extract. After at least 1 week of
acclimatization, mice were studied at 3, 7 and 11 months of age, with the 1H‐MRS in vivo and metabolic tests performed as described below. At
11 months, mice were sacrificed by cervical dislocation under isoflurane anesthesia, and the livers were removed, freeze‐clamped in liquid
nitrogen‐cooled metal tongs and stored at –80°C until further processing.2.2 | Metabolic tests
Oral glucose tolerance tests (OGTTs) were performed after at least a 3‐day resting period following the MR session (described below). Six‐hour
fasted mice (food removed at ~07:30 h) received a glucose load of 1.5 g/kg by oral gavage, and blood glucose was monitored from the tail tip with
a glucometer (Breeze, Bayer, Zürich, Switzerland) for 2 h. The area under the curve (AUC) in the glucose versus time plot was calculated to assess
glucose clearance from the blood. An insulin tolerance test (ITT) was then performed after a minimum 3‐day resting period by intraperitoneal
injection of insulin (0.75 IU/kg, Humulin, Novo Nordisk, Bagsvaerd, Denmark, diluted in 0.9% NaCl). Blood glucose was monitored from the tail
tip for 3 h and the area above the curve (AAC) was calculated for the glucose versus time plots. Commercially available enzyme‐linked immunosor-
bent assay (ELISA) kits were used to measure fasting insulin (Mercodia, Uppsala, Sweden) and C‐peptide (Crystal Chem, Downers Grove, IL, USA)
levels in the plasma. Insulin sensitivity was estimated with the quantitative insulin sensitivity check index (QUICKI) as the inverse of the log10 sum
of fasting insulin (μIU/mL) and fasting glucose (mg/dL).2.3 | HLC and fatty acid composition by 1H‐MRS in vivo
Mice were anesthetized with isoflurane (4% for induction, and 1–2% afterwards, in 70 : 30 air : oxygen) and placed in an in‐house‐built holder.
Body temperature was continuously monitored by a rectal probe and maintained at 36–37°C with a circulating warm water system. The respira-
tory rate was kept at 60–90 bpm by the regulation of isoflurane delivery, and was continuously monitored with a pneumatic pillow through an
MR‐compatible system (SA Instruments, Stony Brook, NY, USA), which also delivered the necessary triggering signals for respiratory gating during
the MR acquisitions. Mice were scanned in the supine position in a 26‐cm, horizontal bore, 14.1‐T magnet interfaced to a VNMRS DirectDrive
console (Varian, Palo Alto, CA, USA). A 1H quadrature surface coil (two 13‐mm inner diameter physically decoupled loops) placed over the
abdomen was used as transreceiver. Automated shimming to reduce magnetic field inhomogeneities was performed with FAST(EST)MAP.22
Multi‐slice gradient echo images were acquired in the sagittal, axial and coronal orientations (flip angle, 85°; field of view, 25 × 25 mm2; data
matrix, 128 × 128; and minimum TR and TE) for the identification of the liver and definition of a 2 × 2 × 2‐mm3 volume of interest for
SOARES ET AL. 3 of 141H‐MRS. HLC was determined from 1H‐MR spectra acquired with the stimulated echo acquisition mode (STEAM) (TE = 8 ms; mixing time, 20 ms;
TR = 6.5 s; 4096 complex points, 32 scans) as the peak area of the methylene protons at 1.3 ppm (Lip 1.3) relative to that of the water plus Lip 1.3,
with corrections for T2 as described previously.
21 The fatty acid composition of intra‐hepatic lipids was characterized as described previously21
using indices for saturation, number of double bonds, unsaturated fatty acids (UFA), saturated fatty acids (SFA), polyunsaturated fatty
acids/polyunsaturated bonds per chain (PUFA), polyunsaturated bonds per UFA, monounsaturated fatty acids (MUFA) and mean chain length
(MCL) (Table 1). These indices were obtained from different lipid resonances in spectra acquired with STEAM (TE = 2.8 ms; mixing time, 20 ms;
TR = 5 s; 2048 complex points; 86–128 scans), in combination with VAPOR [variable power radiofrequency (RF) pulses with optimized relaxation
delays] water suppression and outer volume saturation.23 Individual spectra were corrected for B0 drift and phase, and summed, with peak
integration performed using LCModel24 version 6.3‐1E with SPTYPE liver‐11 and automatic metabolite simulation. The MR experiments, including
animal setup, MR imaging, shimming and 1H‐MRS, lasted for about 1 h.
2.4 | Liver tissue extraction and lipid characterization by HR‐NMR in vitro
About 200 mg of lyophilized liver tissue were treated with chloroform–methanol (2 : 1, v/v) for lipid extraction.25 The organic phase was dried
under a nitrogen atmosphere to prevent oxidation. Dried lipids were dissolved in 500 μL of chloroform‐d for HR‐NMR analysis. Fully relaxed
1H‐NMR spectra of lipid extracts were acquired in a 600‐MHz (14.1‐T) DRX‐600 spectrometer (Bruker BioSpin, Fällanden, Switzerland) equipped
with a cryoprobe, and were obtained with 16 scans of a pulse‐acquire sequence using a pulse delay of 10 s and an acquisition time of 2.5 s. The
equations inTable 1 were used to characterize total lipids extracted from the liver. As a result of the presence of highly unsaturated fatty acids, with
three or more double bonds,21 the equation for MUFA is not applicable to liver extracts. In the HR‐NMR spectra, the contribution of omega‐3
PUFA was calculated from the resonance of the respective terminal methyl groups (Lip 0.9omega‐3), which is shifted downfield relative to the
non‐omega‐3 methyl groups (Lip 0.9), as shown below26:
omega−3 PUFA %ð Þ ¼ Lip 0:9omega−3
Lip 0:9þ Lip 0:9omega−3 ×100
Lipid samples were recovered from the NMR tubes and the solvent was removed by evaporation under a nitrogen atmosphere.
2.5 | Lipidomics by LC‐MS
Standards and solvents are listed in Supporting Information Table S1. Standards were dissolved in chloroform–methanol (1 : 1, v/v) at a
concentration of 1 mM and stored at –20°C. Dried lipid samples were re‐dissolved in chloroform–methanol (1 : 1, v/v) and total phosphate content
was determined to calculate the injection volume corresponding to 0.4 nmol of phosphate. Separation was performed on a HILIC Kinetex column
(2.6 μm, 2.1 × 50 mm2) on a Shimadzu Prominence UFPLC xr system (Tokyo, Japan). Mobile phase A was acetonitrile–methanol (10 : 1, v/v)
containing 10 mM ammonium formate and 0.5% formic acid. Mobile phase B was deionized water containing 10 mM ammonium formate and
0.5% formic acid. Gradient flow elution at 200 μL/min began at 5% B with a linear increase to 50% B over 4 min; 50% B was held for 1.5 min; lastly,
the column was re‐equilibrated for 2.5 min.
Data were acquired in full scan mode at high resolution on a hybrid Orbitrap LTQ‐XL (Thermo Fisher Scientific, Bremen, Germany). The system
was operated at 60 000 resolution (m/z 400) with an automatic gain control (AGC) set at 5.0 × 105 and one microscan set at 250 ms maximum
injection time. The heated electrospray source (HESI II) was operated in positive mode at a temperature of 100°C and a source voltage of 4.0
kV. Sheath gas and auxiliary gas were set at 20 and 5 arbitrary units, respectively, whereas the transfer capillary temperature was set to 275°C.TABLE 1 Fatty acid composition indices derived from 1H‐magnetic resonance (1H‐MR) spectra of hepatic lipids
Saturation index Lip 1:3×3
Lip 0:9×2
Number of double bondsa Lip 5:3&5:2×3
Lip 0:9×2 ×1:15
Unsaturated fatty acids (UFA) Lip 2:1×3
Lip 0:9×4
Saturated fatty acids (SFA) 1 −UFA
Polyunsaturated fatty acids or polyunsaturated bonds per fatty acid (PUFA) Lip 2:8×3
Lip 0:9×2
Polyunsaturated bonds per UFA Lip 2:8×2
Lip 2:1
Monounsaturated fatty acids (MUFA) UFA − PUFA
Mean chain length (MCL) 1=2 Lip 1:3þLip 2:1þLip 2:8ð ÞþLip 5:3&5:2
1=3×Lip 0:9
Chemically distinct fatty‐acyl protons are identified by their chemical shift in the 1H‐MR spectrum; for example, Lip 1.3 refers to the methylene protons at
1.3 ppm.
aA correction factor of 1.15 [1/(1 − 0.13)] was used to account for an underestimation of approximately 13% of the number of double bonds under our
acquisition parameters.21
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carried out with Lipid Data Analyzer II (LDA v. 2.5.1, IGB‐TUG Graz University, Graz, Austria).27 This algorithm identifies peaks by their respective
retention time, m/z and intensity. In order to minimize the number of potential elemental assignments, care was taken to calibrate the instrument
regularly to ensure a mass accuracy consistently lower than 3 ppm.
The total amount of phosphate was similar in the lipid extracts from male and female livers (17.93 ± 0.6 and 17.02 ± 2 nmol/mg, respectively),
thereby allowing for a direct qualitative comparison of lipid species abundance between samples of both sexes. An initial coarse evaluation of the
differences between sexes was performed by comparing the total signal area of each lipid class on the total ion chromatogram. The most abundant
lipid classes were further evaluated by comparing the relative distribution of individual species identified by Lipid Data Analyzer II within the class.
The contribution of individual species is expressed as the percentage ratio of their extracted ion chromatogram area versus the summed area of all
lipid species identified in the class, in a similar manner to Rouzer et al.28 Only species contributing to more than 1% of the total signal of the class in
at least one of the sexes were considered.2.6 | Statistics
The reported values are the mean ± standard error of the mean (SEM). Statistical significance was accepted for p < 0.05 as determined by two‐way
analysis of variance (ANOVA) with Bonferroni post‐hoc correction, when comparing variables between male and female mice during the
longitudinal assessments. For specific comparisons within the same sex at different ages, a one‐way ANOVA was used. Differences in fatty acid
composition indices obtained by HR‐NMR and in lipid class levels between sexes were assessed using an unpaired Student's t‐test. Correlations
were assessed by the Pearson r coefficient and significance was accepted for p < 0.01.3 | RESULTS
3.1 | Baseline metabolic status
The baseline assessment of the glycemic response to an oral glucose load, performed at 3 months of age, was similar between both sexes (Figure 1A,
3 months), but the response to an insulin challenge was different (Figure 1B, 3 months). At 3 months, male mice showed higher blood glucose than
females at 3 h post‐ITT (6.7 ± 0.6 mM versus 4.5 ± 0.4 mM, p < 0.01, Figure 1G), but a similar blood glucose drop during the first hour of ITT
(Figure 1F) and AAC (Figure 1H). Fasting glucose values were comparable in male and female mice at 3 months (time = 0 of measurements at
3 months in Figure 1A,B). Sex differences in fasting insulin did not reach statistical significance (Table 2), but QUICKI was lower in male than
in female mice (p < 0.05, Figure 1C). C‐peptide levels were higher in male than in female mice (p < 0.001, Table 2). Taken together, these obser-
vations indicate that, at baseline, male mice are less sensitive than female mice to insulin and display higher insulin secretion in the fasted state, as
indicated by C‐peptide measurements.
The metabolic evaluation was completed with non‐invasive measurements of hepatic lipids by 1H‐MRS in vivo. At baseline, male mice displayed
lower HLC than females (p < 0.01, Table 2). However, and as expected, body weight at baseline was higher in males than in females (Table 2). The
fatty acid composition of cytosolic lipids was characterized with indices derived from the different 1H lipid resonances visible with water
suppression (Figure 2A and Table 1). These indices report the average unsaturation and length of the composite hepatic fatty acids, and some
differences between male and female mice could be detected at baseline. Namely, the saturation index was smaller in males relative to females
(6.2 ± 0.2 versus 7.7 ± 0.5, p < 0.05, Figure 3A). This index reflects the abundance of methylene protons and depends on both the saturation level
and chain length. As indices for the number of double bonds, UFA, PUFA andMUFA were similar between both sexes, the observed difference may
be ascribed to shorter fatty acids in male mice (MCL: 14.0 ± 0.3 versus 15.7 ± 0.5, p < 0.05, Figure 3B).3.2 | Evolution of the metabolic status with age
With age, body weight increased in both sexes, and male mice at all ages had higher body weight than female mice (Table 2). Blood glucose after a
6‐h fast (time = 0 in graphs in Figure 1A,B) did not change with age or sex. Plasma insulin levels did not change with age in either sex, but were
higher in male mice throughout the study (p < 0.001 for sex with two‐way ANOVA). As a result, male mice showed a lower QUICKI than females
at all time points assessed (Figure 1C). C‐peptide levels did not change with age in either sex, but were always higher in males than in females
(Table 2). There were clear changes with age in the glucose curves obtained during OGTT (Figure 1A) and ITT (Figure 1B) in male mice, but not
in female mice. These changes are clearly apparent in Figure 1D–H, depicting the longitudinal evolution of OGTT and ITT parameters. Blood
glucose at 2 h post‐OGTT (Figure 1D) diverged from similar baseline values and was significantly higher in males than in females at 7 months
(7.5 ± 0.3 mM versus 10.9 ± 0.5 mM, p < 0.0001) and 11 months (7.8 ± 0.3 mM versus 11.3 ± 0.4 mM, p < 0.0001). In female mice, blood glucose
at 2 h post‐OGTT decreased with age (p < 0.05), whereas no significant changes were noticed in males. The AUCs during OGTT were similar
between male and female mice at all ages and did not change with age (Figure 1E). ITT parameters did not change with age in female mice
(Figure 1F–H). In males, AAC decreased at 7 and 11 months relative to baseline (Figure 1H). This decrease was ascribed to a smaller drop in blood
FIGURE 1 Evolution of the metabolic performance of male and female mice. Blood glucose oscillations during the oral glucose tolerance test
(OGTT) A and the insulin tolerance test (ITT) B, for three time point assessments: 3, 7 and 11 months. The longitudinal evolution of the
quantitative insulin sensitivity check index (QUICKI) C and parameters obtained from the OGTT D, E and ITT F–H, is also shown. Data from male
mice are shown as black circles and full lines, and data from female mice are shown as white triangles and dotted lines.*p < 0.05, **p < 0.01, ***p <
0.001, **** p < 0.0001 versus females of the same age [two‐way analysis of variance (ANOVA) and Bonferroni post‐hoc test]. ap < 0.05, bp < 0.01,
cp < 0.001 versus 3 months within the same gender (one‐way ANOVA and Bonferroni post‐hoc test)
SOARES ET AL. 5 of 14glucose during the first hour of ITT (Figure 1F), as blood glucose at 3 h post‐ITT was similar to that observed at baseline (7.4 ± 0.4 mM at 7 months
and 6.8 ± 0.4 mM at 11 months, Figure 1G).
HLC increased in male mice from baseline to 7 months without further changes (Table 2). Hence, unlike observations at baseline, no
differences in HLC were observed between male and female mice at 7 and 11 months (Table 2). HLC strongly correlated with body weight in male
(r = 0.67, p = 0.0001), but not female, mice. The saturation index of hepatic cytosolic fatty acids also increased in male mice with age (from 6.2 ± 0.2
at baseline to 7.7 ± 0.3 at 7 months, p < 0.05, and 7.5 ± 0.4 at 11 months, p < 0.05, Figure 3A). This change was clearly apparent in the lipid spectral
signatures obtained by 1H‐MRS in vivo from the livers of male mice at the different ages. As depicted in Figure 2B, the resonance height (main con-
tributor to resonance area) of methylene protons (Lip 1.3) increases relative to that of methyl protons (Lip 0.9), when comparing spectra acquired at
TABLE 2 Body weight, pancreatic hormones and hepatic lipid content at 3, 7 and 11 months of age in male and female mice
Body weight (g) Fasting insulin (μU/mL) Fasting C‐peptide (ng/mL) Hepatic lipid content (%)
Age (months) Male mice Female mice Male mice Female mice Male mice Female mice Male mice Female mice
3 24.8 ± 0.4 20.2 ± 0.3 8.4 ± 2.8 2.0 ± 0.2 0.7 ± 0.1b 0.2 ± 0.02 1.4 ± 0.1a 2.7 ± 0.2
7 32.8 ± 0.6 23.9 ± 0.7 17.3 ± 5.6a 1.5 ± 0.4 0.8 ± 0.1b 0.2 ± 0.02 2.9 ± 0.3c 2.2 ± 0.2
11 35.0 ± 0.8 26.0 ± 0.4 12.2 ± 4.5 1.8 ± 0.2 0.9 ± 0.2b 0.2 ± 0.02 2.7 ± 0.3d 2.2 ± 0.1
The body weight was always higher in males and increased with age for both sexes [p < 0.0001, two‐way analysis of variance (ANOVA) with Bonferroni post‐
hoc test].
ap < 0.01 and
bp < 0.001 versus females of the same age (two‐way ANOVA with Bonferroni post‐hoc test)
cp < 0.01 and
dp < 0.05 versus 3‐month‐old males (one‐way ANOVA with Bonferroni post‐hoc test).
(A)
(B)
FIGURE 2 Lipid and other metabolite resonances observed in mouse liver by 1H‐magnetic resonance spectroscopy (1H‐MRS) in vivo. A, The
general structure of triglyceride is shown for the identification of the different types of protons in fatty acids, which are labeled according to
their chemical shift in the 1H‐MR spectrum acquired with water suppression from the liver of a female mouse at 7 months. B, Alterations with age
of the spectral signature observed in male mice in the region from 0.5 to 1.5 ppm. The spectra are the sum of those obtained from all male mice at a
given age. The broken lines illustrate the increase in the resonance height of Lip 1.3 relative to that of Lip 0.9 (used for normalization to one fatty
acid chain) when comparing spectral profiles at 7 and 11 months with that at 3 months
6 of 14 SOARES ET AL.7 and 11 months to those acquired at baseline (3 months). The modification of the saturation index with age in males was not accompanied by
significant alterations in fatty acid unsaturation indices (double bonds, UFA, PUFA, MUFA, Figure 3C–H) or chain length (Figure 3B). Nevertheless,
the combined trends for decreased overall unsaturation (double bonds, UFA) and longer chains seem to explain the increase in the saturation index
from baseline to 7 and 11 months.3.3 | Associations between metabolic variables
Correlations between changes in glucose metabolism, increasing body weight and HLC were obtained by combining the datasets from all the
longitudinal time points (Table 3). Significant correlations were found between ITT and OGTT parameters and body weight and HLC in male,
but not female, mice. There was a small, but significant, positive correlation between body weight and glycemia at 2 h post‐OGTT, and strong
negative correlations between body weight and ITT parameters, such as AAC and blood glucose drop during the first hour. However, HLC was
(A) (B)
(C) (D)
(E) (F)
(G) (H)
FIGURE 3 Indices of fatty acid composition of cytosolic lipids determined longitudinally by 1H‐magnetic resonance spectroscopy (1H‐MRS)
in vivo and of total lipids determined at 11 months by high‐resolution, liquid‐state, nuclear magnetic resonance (HR‐NMR) ex vivo. Data from
male mice are shown as black circles and solid lines, and from female mice as white triangles and dotted lines. FA, fatty acid; PU, polyunsaturated;
PUFA, polyunsaturated fatty acid; UFA, unsaturated fatty acid. ap < 0.05 versus females of the same age [two‐way analysis of variance (ANOVA)
with Bonferroni post‐hoc test]. bp < 0.05 versus 7‐ and 11‐month males (one‐way ANOVA with Bonferroni post‐hoc test). *p < 0.05, **p < 0.01,
***p < 0.001 determined by unpaired Student's t‐test
SOARES ET AL. 7 of 14exclusively correlated with ITT parameters. Similar to body weight, there was a negative correlation between HLC and both AAC and blood glucose
drop during the first hour. In addition, HLC also showed good correlation with blood glucose at 3 h post‐ITT and with fasting insulin.3.4 | Endpoint lipidomics of total hepatic lipids
To complement our longitudinal measurements in vivo, total liver lipids were characterized post‐sacrifice, at 11 months of age, by HR‐NMR and
LC‐MS methods. Indices for chain length (Figure 3A,B) and polyunsaturation (Figure 3C–E) obtained from HR‐NMR spectra ex vivo were
consistently higher than those found by 1H‐MRS in vivo, whereas the UFA index was comparatively lower (Figure 3G). The most abundant
membrane phospholipid class, phosphatidylcholine (PtdCho), was clearly identified in the HR‐NMR spectra by the resonance of its methyl
protons at 3.2 ppm (Figure 4). Bis‐allylic protons (Lip 2.8) in diunsaturated fatty acids (DUFA) were resolved from those in chains with a higher
degree of polyunsaturation (PUFA), visible at a lower field frequency (Figure 4). In female liver samples, the resonances of olefinic (Lip 5.3) and
bis‐allylic protons from PUFA were consistently higher than those in male liver samples (Figure 4), translating into a higher average number of
double bonds and polyunsaturation indices when comparing the composition of total lipids between the two sexes (Figure 3C–E). Finally, from
TABLE 3 Correlations between metabolic parameters, body weight and hepatic lipid content in male and female mice during the longitudinal
follow‐up
Male mice Female mice
Body weight HLC Body weight HLC
Pearson r p value Pearson r p value Pearson r p value s p value
OGTT parameters
AUC 0.21 ns 0.05 ns –0.26 ns 0.15 ns
Glycemia2h‐post 0.49 <0.01 0.33 ns –0.46 ns 0.32 ns
ITT parameters
AAC –0.62 <0.001 –0.69 <0.001 0.12 ns 0.04 ns
Glycemia drop1h‐post –0.68 <0.001 –0.57 <0.01 –0.02 ns 0.22 ns
Glycemia3h‐post 0.20 ns 0.55 <0.01 –0.25 ns 0.33 ns
6‐h fasting parameters
Glucose 0.83 ns 0.47 ns –0.17 ns 0.2691 ns
Insulin 0.39 ns 0.51 <0.01 0.05 ns 0.18 ns
C‐peptide 0.19 ns 0.07 ns –0.01 ns 0.18 ns
QUICKI –0.21 ns –0.38 ns –0.08 ns –0.39 ns
AAC, area above the curve; AUC, area under the curve; HLC, hepatic lipid content; ITT, insulin tolerance test; OGTT, oral glucose tolerance test; QUICKI,
quantitative insulin sensitivity check index.
FIGURE 4 Representative high‐resolution, liquid‐state, nuclear magnetic resonance (HR‐NMR) spectra of total lipids extracted from the liver of
one male and one female mouse. Spectra are scaled to the resonance of the terminal methyl group (Lip 0.9) and spectral differences are shaded
in gray. For identification of the lipid resonances in the fatty acid chain, see Figure 2. Distinct spectral differences correspond to higher numbers of
double bonds (i), polyunsaturated double bonds per fatty acyl chain and unsaturated fatty acyl chain (ii) and omega‐3 PUFA (iii). DUFA,
diunsaturated fatty acid; PtdCho, phosphatidylcholine; PUFA, polyunsaturated fatty acid; SM, sphingomyelin
8 of 14 SOARES ET AL.HR‐NMR spectra, we estimate that omega‐3 PUFA represented 12 ± 0.6% of the fatty acids in total lipids in females and a significantly lower
proportion, 10 ± 0.5% (p < 0.01), in males.
To obtain detailed insight into lipid classes and species distribution profiles, we performed LC‐MS for lipid separation, identification and
relative quantification (Figure 5). The abundance of certain lipid classes exhibited sexual dimorphism, whereas others occurred in similar amounts
in both sexes (Figure 5A). In particular, the levels of triglycerides (TG), the principal cytosolic lipids, were similar between male and female liver
samples. The levels of diacylglycerols in female liver samples were about one‐half of those found in males. No differences were found in the levels
of the principal class of membrane phospholipids (PtdCho), but the abundance of phosphatidylinositols (PtdIns) and phosphatidylethanolamines
(PtdEt) was higher in female than in male livers, whereas phosphatidylglycerols (PG) were lower in female than in male liver samples. We also found
differences in a less prominent class, lyso‐bis‐phosphatidic acid (LBPA), whose levels were increased in the livers of female mice relative to males.
We further investigated the species distribution profile of major lipid classes, i.e. TG and the principal membrane phospholipids PtdCho, PtdEt,
PtdIns and sphingomyelins (SM). InTG, species 54:4 existed in a larger proportion in liver lipids from female, relative to male, mice, which, instead,
showed a larger proportion of species 52:4 (Figure 5B). More pronounced differences in the species distribution profile were found in membrane
phospholipids. PtdCho (Figure 5C) from female livers showed a higher proportion of very long chain and highly polyunsaturated species (38:4; 38:5,
38:6, 40:6) than that found in PtdCho from male livers. Conversely, male livers exhibited a higher proportion of shorter PtdCho with up to three
double bonds (34:1; 34:2, 36:3). A greater abundance of highly unsaturated species was also observed in PtdEt (Figure 5D) from female liver
(A) (B)
(C) (D)
(E) (F)
FIGURE 5 Sexual dimorphism in liver lipid classes A, and species B–F, assessed by liquid chromatography‐mass spectrometry (LC‐MS). When
comparing lipid classes between genders A, significant differences from zero, with zero denoting no change, are marked for §p < 0.05, §§p <
0.01, §§§P < 0.001 and §§§§p < 0.0001. The percentage contribution of lipid species to the total class is shown in B–F, in male (black bars) and female
(white bars) liver samples, and differences between genders are marked for *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001 [two‐way analysis
of variance (ANOVA) and Bonferroni multiple comparison post‐hoc test]. Unless specified otherwise, lipid species are tri‐ or di‐acylated molecules.
Cer, ceramides; DAG, diacylglycerols; GlcCer, glucosylceramides; LBPA, lyso‐bis‐phosphatidic acid; PG, glycerophosphoglycerols; PtdCho,
phosphatidylcholines; PtdEt, phosphatidylethanolamines; PtdIns, phosphatidylinositols; PtdSer, Phosphatidylserines; SLBPA, semi‐lyso‐bis‐
phosphatidic acid; SM, sphingomyelins; TG, triglycerides
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species distribution profile, with females showing a higher contribution from shorter monounsaturated species 34:1 and 36:1, but also from longer
polyunsaturated species 42:2 and 42:3. However, the most abundant SM species in males was 40:1, reaching a proportion that was twice that
found in females. Other SM species more abundant in males were 40:2 and 42:1. The principal PtdIns (Figure 5F) species 38:4 showed a higher
relative content in female than in male liver samples.
Finally, we investigated the association between the most prominent changes in total liver lipids and the metabolic parameters of the
corresponding mice at the age of 11 months (Figure 6). In female mice, the percentage contribution of omega‐3 PUFA was strongly correlated with
insulin sensitivity assessed by QUICKI (Figure 6A, r = 0.78, p < 0.01). Except for this association, no other significant correlation was found between
metabolic performance and total lipid components in a sex‐specific manner. However, several correlations were present when analyzing male and
female mice together, probably as a result of a sex‐related clustering effect. In brief, insulin sensitivity (QUICKI and ITT parameters) increased with
omega‐3 PUFA (Figure 6A,B) and PtIns (Figure 6C–E), which were both higher in female liver samples (Figure 5A), and decreased with lipid classes
more prominent in males, i.e. PG (Figure 6F) and diacylglycerols (Figure 6G). Glucose tolerance declined with increasing PG levels (Figure 6H, I),
higher in male liver samples.
(A) (B) (C)
(D) (E) (F)
(G) (H) (I)
p
p
p p
p
p p
p
p
FIGURE 6 Significant correlations between total lipid components exhibiting sexual dimorphism and metabolic scores. Metabolic performance was
characterized from the quantitative insulin sensitivity check index (QUICKI), blood glucose at 3 h post‐ITT, area above the curve for blood glucose
oscillations during ITT, blood glucose drop during the first hour of ITT, blood glucose at 2 h post‐OGTT and area under the curve for blood glucose
oscillations during OGTT. Males are represented with black circles and females with white triangles. DAG, diacylglycerols; ITT, insulin tolerance
test; OGTT, oral glucose tolerance test; PG, glycerophosphoglycerols; PtdIns, phosphatidylinositols; PUFA, polyunsaturated fatty acids
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We followed glucose homeostasis and hepatic lipids in aging male and female mice housed under standard conditions with free access to a regular
chow diet. We observed age‐related changes in glucose homeostasis in male mice, which correlated with weight gain and HLC. As expected, the
metabolic performance diverged significantly between male and female mice, but the sexually dimorphic response to glucose and insulin challenges
was not accompanied by sex differences in HLCor fatty acid composition, asmonitored by 1H‐MRS in vivo. Instead, further lipid profiling byHR‐NMR
and LC‐MS revealed striking sexual dimorphism in lipid membrane species, supporting a link between biologically active lipid intermediates, not
necessarily stored TG, and susceptibility to metabolic dysregulation in aged mice.
We used different approaches to assess hepatic lipids, and each method has particular strengths and limitations. Non‐invasive 1H‐MRS in vivo
is highly suited to longitudinal measurements and exclusively detects mobile lipids in the cytosol. Conversely, both HR‐NMR and LC‐MS
additionally detect the membrane lipids dissolved in the organic medium during the extraction procedure. Relative to HR‐NMR, LC‐MS is more
sensitive for the detection of less abundant species and is better able to resolve the various classes and species in the total lipid mixture. The fatty
acids observed by 1H‐MRS in vivo are mainly constituents of TG, which account for over 95% of the lipid content in cytosolic lipid droplets from
murine hepatocytes.29 1H‐MRS in vivo indicated similar HLC between male and female mice at 11 months of age (Table 2), in agreement with the
similar TG content determined by LC‐MS in the respective liver tissue extracts (Figure 5A). LC‐MS and lipidomics analysis reported modest
differences inTG species between the two sexes. Such differences were not apparent in the indices reporting the averaged composition of hepatic
fatty acids estimated from 1H‐MR spectra acquired in vivo, which were similar betweenmale and female mice at 11 months of age (Figure 3, 1H‐MRS
in vivo graphs). In rodentmodels of hepatic steatosis18,19,30 and diabetes,21 differences in fatty acid composition could be detected by 1H‐MRS in vivo,
supporting the value of this technique in monitoring the remodeling of cytosolic fatty acids within the scope of severe metabolic impairments.
Compared with the indices obtained by 1H‐MRS in vivo, HR‐NMR ex vivo reported a higher number of double bonds and degree of
polyunsaturation, and lower UFA, reproducing our previous observations21 and indicating the presence of membrane‐derived fatty acids that
are not detected by 1H‐MRS in vivo. We found distinct HR‐NMR spectral signatures between male and female total lipid samples (Figure 4). and
therefore differences in several fatty acid composition indices (Figure 3, HR‐NMR ex vivo graphs). As HLC and indices determined by 1H‐MRS in vivo
were similar between the sexes at 11 months, these differences indicate sexual dimorphism in the fatty acid composition of membrane lipids.
Indeed, lipidomics after LC‐MS separation and identification showed that the principal membrane lipids, PtdCho and PtdEt, were characterized
by a greater contribution of highly polyunsaturated lipid species in the livers of female mice, relative to males (Figure 5C,D), similar to findings from
other authors.31-33 These lipid data provide an explanation for the higher average number of double bonds and polyunsaturated bonds, estimated
from HR‐NMR spectra, in female liver samples, when comparing with males.
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glucose and insulin challenges. In both cases, the decrease in blood glucose is driven by insulin‐dependent stimulation of peripheral glucose
uptake and inhibition of hepatic glucose production. Glucose production following a glucose load is suppressed after a 20‐min delay,34 but
this pathway still contributes one‐third to plasma glucose in the last hour of OGTT.35,36 Therefore, adjustments of hepatic glucose
production in response to insulin are mostly reflected in the last time points of the metabolic tests. In male mice, we found excellent
correlations between HLC and parameters from ITT, a test that enables a direct assessment of basal insulin sensitivity.37 Of note, blood
glucose at 3 h post‐ITT showed good correlation with HLC independent of body weight (Table 3). Such specificity supports a close relation
between HLC and insulin‐mediated adjustments of glucose production at the end of the test. HLC also correlated with fasting insulin levels,
which reflect insulin sensitivity.38 No correlation was found between HLC and fasting C‐peptide concentrations in the blood of male mice,
indicating that insulin secretion was not compromised with increasing HLC. A study using a short‐term high‐sucrose diet also failed to find
evidence of perturbed insulin secretion, despite the presence of hepatic steatosis and fasting hyperinsulinemia in rats.39 Therefore, at least
in this study and ours, a less efficient hepatic insulin extraction appears to be a common mechanism that links increased HLC to peripheral
hyperinsulinemia. It should be noted that HLC observed in our study is within the normal range18,21 and below the 5–20% range found in
models of liver steatosis.18,19,40 As increased hepatic insulin exposure is known to contribute to the metabolic dysregulation in chronic
steatosis,41 the relationship between HLC and hepatic insulin extraction may depend on the extent of hepatic steatosis. In contrast with
ITT, OGTT explores the action of endogenous insulin secreted by the pancreas.38,42 Although HLC and OGTT parameters have been
reported to correlate in experimental liver steatosis,35 we did not find a correlation in the current study. Instead, OGTT performance changed
over time in male mice in correlation with their body weight. Although we measured fasting insulin and C‐peptide concentrations, the lack of
information on the excursions of these pancreatic hormones during OGTT limits our ability to assess changes in glucose‐stimulated insulin secre-
tion. Perturbed β‐cell function could explain, at least in part, aging‐induced glucose intolerance in male mice. In support of this notion, aged mice
show a comparative lack of β‐cell plasticity to adapt to metabolic insults, such as high‐fat diet feeding.43 Both insulin action and secretion after
the ingestion of a mixed meal decrease with age in men, but not in women.44 However, both men and women show increased hepatic insulin
extraction with age,44 and this would also reduce peripheral insulin exposure, thereby influencing the dynamics of the glycemic response to
the glucose challenge.
Although, in male mice, HLC strongly correlated with body weight, this correlation was absent in females (Table 3). In ad libitum‐fed
rats, increased body weight with age is associated with the expansion of visceral fat mass,5 and visceral fat expansion contributes directly
to hepatic lipid accumulation in obese mice.45 Therefore, visceral fat possibly mediates the increase in HLC associated with body weight in
male mice in our study. In contrast, the lack of hepatic lipid accumulation in female mice, which nonetheless displayed increasing body
weight, could relate to a better capacity for estrogen‐promoted subcutaneous fat storage.46 Indeed, experimentally induced estrogen
deficiency results in increased visceral fat mass47 and ectopic lipid deposition in the liver.48 By their action on hepatic lipid metabolism,
estrogens are also known modulators of insulin sensitivity.49 Interestingly, under normal conditions. hepatic lipid levels are comparable
between both sexes, or even higher in females, as observed in this and other studies.50,51 In addition, the association of insulin sensitivity
with HLC was absent in females, which showed better scores than males with the same hepatic lipid load, i.e. at the older ages of 7 and
11 months (Table 2 and Figure 1). Therefore, the amount of stored lipids in the liver, reported by both 1H‐MRS in vivo and LC‐MS as TG,
appears to be unrelated to the sexual dimorphism in metabolic health.
As demonstrated by studies with genetically modified mice accumulating TG in the liver, hepatic steatosis may be dissociated from insulin
resistance.52 Rather than hepatic TG per se, lipotoxic non‐TG lipids contribute to metabolic disease.53-55 In correlation with metabolic scores, we
found that several non‐TG lipids with biological activity exhibited sexual dimorphism in aged mice. Diacylglycerols are implicated in insulin
resistance by their ability to perturb the insulin signaling cascade via protein kinase C (PKC).56,57 Diacylglycerols are intermediate species in the
biosynthesis of TG, but may also be generated from membrane phospholipids. Membrane PtdIns, in particular, has been suggested as a relevant
source of diacylglycerols for PKC activation.58,59 At 11 months, male mice showed higher hepatic levels of diacylglycerols than female mice and,
conversely, lower levels of PtdIns. Indeed, there was a negative correlation between the levels of these two classes when considering male and
female mice together (r = –0.68, p < 0.001). The release of diacylglycerols from membrane PtdIns in males, with the effect on PKC signaling, could
explain their lower insulin sensitivity relative to females. Sexual dimorphism in diacylglycerols and PtdIns was strongly correlated with insulin
sensitivity reported by ITT parameters (Figure 6B,C,F and G). These findings are in good agreement with a study showing that estradiol
administration to ovariectomized mice strongly reduced hepatic diacylglycerol levels and PKC activation.60
In agreement with other studies,28,61 the great majority of PtdIns were C38:4 species, i.e. with one C18:0 (stearoyl) and one C20:4
(arachidonyl) chain. PtdIns is selectively enriched with arachidonic acid via recycling of PtdIns‐derived diacylglycerols and chain remodeling.62,63
Because arachidonic acid is a precursor to pro‐inflammatory eicosanoids,62,64 its incorporation in membrane PtdIns reduces intracellular
inflammation by controlling arachidonic acid levels. Accordingly, the maintenance of metabolic control in female mice is indeed associated with
the absence of inflammatory liver damage in the face of hepatic lipid accumulation.15 In addition, female rats have been shown to display a higher
capacity to synthesize the anti‐inflammatory omega‐3 PUFA, docosahexanoic acid,33,65 a mechanism mediated by estrogens.66 In line with these
reports, we detected higher amounts of omega‐3 PUFA in total liver lipids of female than male mice. Given the association of metabolic disease
with inflammation,6,64 a higher pro‐inflammatory tonus in males could also account for the sex‐specific changes in metabolic health in our study.
Levels of omega‐3 PUFA were indeed strongly correlated with metabolic health parameters in our experimental paradigm (Figure 6D,E).
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This study shows that decreasing insulin sensitivity evolves in association with increasing HLC in male mice housed under standard conditions, but
not in females. This finding was not accompanied by marked sex‐related differences in the fatty acid composition of the major cytosolic lipids, as
determined by both 1H‐MRS in vivo and LC‐MS. We found strong sexual dimorphism in diacylglycerol, PtdIns and omega‐3 PUFA content in aged
mice. Rather than stored TG, it is these bioactive lipids, whose levels are modulated by estrogen activity,60,66 that influence the evolution of the
metabolic performance of mice housed under standard conditions. In males, increases in the hepatic cytosolic lipid load without proportional
compensation from bioactive lipids probably explains the association of insulin sensitivity with HLC.
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